Prof. Dr. med. Heinz Reichmann

Medical Degrees

• Medical Graduation (MD) — University of Freiburg, Germany, 1979
• Doctoral Dissertation (Dr. med.) — University of Freiburg, Faculty of Medicine, 1979 (on kinetics of strophanthin binding to the erythrocyte membrane)
• PhD — University of Freiburg, Germany
• Full Professorship in Neurology — University of Würzburg, 1990

Fellowships & Special Training

• Research Fellowship — Institute for Biochemistry, University of Konstanz, Germany (1980–1983)
• Research Fellowship — Institute of Neurology, Columbia University, New York City, USA
• German Research Foundation (DFG) and Fritz Thyssen Foundation Scholarship (Special programme for highly gifted young scientists), 1980–1983
• Fellowship of the Royal College of Physicians (FRCP)
• Fellowship of the European Academy of Neurology
• Fellowship of the American Academy of Neurology
• Honorary Member — Japanese Neurological Society

Certifications & Accreditations

• German Medical Association (Bundesärztekammer) Registration
• Saxony Medical Chamber (Sächsische Ärztekammer) — Registered Specialist
• Board-Certified Specialist — Neurology, Germany
• Adjunct Professor — University of Aalborg, Denmark

Major Conditions Treated

• Parkinson's Disease & Parkinsonian Syndromes
• Movement Disorders (Dystonia, Tremor, Chorea)
• Muscle Disorders (Mitochondrial Myopathies, Muscular Dystrophy)
• Epilepsy
• Stroke & Cerebrovascular Disease
• Multiple Sclerosis
• Peripheral Neuropathy
• Headaches & Migraine
• Spinal Cord Disorders
• Dementia & Alzheimer's Disease
• Neurodegenerative Diseases
• Restless Legs Syndrome

Sub-specialties

• Parkinson's Disease & Movement Disorders: International authority on Parkinson's disease, premotor symptoms, and the gut-to-brain hypothesis — a trusted neurologist specialist in Dresden, Germany.
• Muscle Disorders & Mitochondrial Myopathies: Specialised research and clinical management of mitochondrial myopathies and muscular dystrophies.
• Deep Brain Stimulation & Advanced Parkinson's Therapies: Complex Parkinson's therapy including deep brain stimulation and apomorphine/levodopa pumps.
• Neuroprotection Research: Pioneering research on energy metabolism and neuroprotection in Parkinson's disease — for international patients seeking best neurology treatment in Germany.
• Basal Ganglia & Neurodegenerative Research: Biochemical and molecular research on Parkinson's disease.
• Alpha-Synuclein Research: Contributions to understanding α-synuclein protein aggregation in Parkinson's pathogenesis.

Advanced Procedures & Treatments

• Deep Brain Stimulation (DBS) for Parkinson's Disease
• Levodopa / Apomorphine Infusion Pump Therapy
• Modern Medication Therapy for Parkinson's Disease
• Botulinum Toxin Therapy for Dystonia and Movement Disorders
• Mitochondrial Myopathy Diagnosis & Management
• Comprehensive Parkinson's Disease Complex Treatment
• Muscle Biopsy & Diagnostics
• EEG, EMG & Nerve Conduction Studies
• Acute Stroke Management
• Multiple Sclerosis Disease-Modifying Therapy
• Epilepsy Management
• Neurorehabilitation Coordination

Current Affiliation

• University Hospital Carl Gustav Carus, TU Dresden, Fetscherstraße 74, 01307 Dresden, Germany — Director, Department of Neurology, Since 1996
• TU Dresden — Professor of Neurology
• University of Aalborg, Denmark — Adjunct Professor

Past Affiliations

• TU Dresden — Dean of the Medical Faculty (for more than 16 years)
• University Hospital Bonn — Board Director
• University of Würzburg — Professor of Neurology (1990) and Board Member of the Faculty of Medicine (1992–1996)
• University of Würzburg — Ethics Committee Member (1992–1996)
• Columbia University, New York — Research Fellow at the Institute of Neurology
• University of Konstanz — Research Fellow at the Department of Biochemistry (1980–1983)
• University of Freiburg — Medical Graduation and Dissertation (1979)

Academic & Research Roles

• Professor of Neurology and Past Dean of the Medical Faculty, TU Dresden
• Past President — European Neurological Society (ENS)
• Past President — German Neurological Society (DGN)
• Past President — German Parkinson Society (DPG)
• Past President — German Muscle Society
• Initiator — European Academy of Neurology (EAN, founded 2014)
• Honorary Member — Japanese Neurological Society
• Honorary Member — Controversies in Neurology (CONy)
• Editorial Board Member — Multiple prestigious neurology journals
• Author — 1,183+ scientific publications

Key Achievements

• 44+ years of clinical and academic experience
• Chairman of Department of Neurology at University of Dresden since 1996
• Dean of Medical Faculty at TU Dresden for over 16 years
• Past President of four major neurology societies
• Initiator of the new European Academy of Neurology
• 1,183+ scientific publications
• Fellow of Royal College of Physicians, European Academy of Neurology, and American Academy of Neurology
• Adjunct Professor at University of Aalborg, Denmark

National & International Awards

• Heinrich Pette Prize — German Neurological Society
• Prize for Research on the Central Nervous System in the Elderly, 1993
• Honorary Member — Japanese Neurological Society
• Fellow of the Royal College of Physicians (FRCP)
• Fellow of the European Academy of Neurology (FEAN)
• Fellow of the American Academy of Neurology (FAAN)
• German Research Foundation (DFG) and Fritz Thyssen Foundation Scholarship for Highly Gifted Young Scientists, 1980–1983

Professional Memberships

• German Neurological Society (DGN) — Past President
• German Parkinson Society (DPG) — Past President
• European Neurological Society (ENS) — Past President
• European Academy of Neurology — Fellow
• American Academy of Neurology (AAN) — Fellow
• American Neurological Association (ANA) — Member
• Royal Society of Medicine — Member
• Movement Disorder Society (MDS) — Member
• Royal College of Physicians (FRCP) — Fellow
• German Muscle Society — Past President

Published Papers (Selected)

• Pan-Montojo F, Anichtchik O, Dening Y, Knels L, Pursche S, Jung R, Jackson S, Gille G, Spillantini MG, Reichmann H, Funk RH. "Progression of Parkinson's disease pathology is reproduced by intragastric administration of rotenone in mice." PLoS ONE 2010;5(1):e8762.
• Pan-Montojo F, Schwarz M, Winkler C, Arnhold M, O'Sullivan GA, Pal A, Said J, Marsico G, Verbavatz JM, Rodrigo-Angulo M, Gille G, Funk RH, Reichmann H. "Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice." 2012.
• Reichmann H, Lestienne P, Jellinger K, Riederer P. "Parkinson's disease and the electron transport chain in postmortem brain." Adv Neurol 1993;60:297–299.
• Lestienne P, Nelson J, Riederer P, Jellinger K, Reichmann H. "Normal mitochondrial genome in brain from patients with Parkinson's disease and complex I defect." J Neurochem 1990;55(5):1810–1812.
• Riederer P et al. Research with Reichmann on alpha-synuclein aggregation in Parkinson's disease (2019).
• Becker et al. Research with Reichmann on alpha-synuclein (1995).
• 1,183+ peer-reviewed publications in total (ResearchGate).

Ongoing Research & Clinical Interests

• Energy metabolism and neuroprotection in Parkinson's disease
• Premotor symptoms in Parkinson's disease
• Etiopathogenesis and treatment of Parkinson's disease
• Mitochondrial myopathies and biochemical aspects of Parkinson's
• Gut-to-brain hypothesis in Parkinson's pathophysiology
• Alpha-synuclein protein aggregation
• Tryptophan derivatives in Parkinson's disease

*Indicative estimates only. Actual costs subject to hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote.